C12N 2710/16741
Use of virus, viral particle or viral elements as a vector
C12N2710/16741 (Use of virus, viral particle or viral elements as a vector) appears on 82 US grants and 45 published applications in this corpus.
Search patents in C12N- Granted patents
- 82
- Published applications
- 45
- Assignees
- 56
- Inventors
- 143
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 11 | 0 |
| 1999 | 2 | 0 |
| 2000 | 8 | 0 |
| 2001 | 5 | 0 |
| 2002 | 7 | 2 |
| 2003 | 1 | 4 |
| 2004 | 4 | 2 |
| 2005 | 0 | 2 |
| 2006 | 1 | 5 |
| 2007 | 3 | 0 |
| 2008 | 1 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 7 |
| 2019 | 2 | 2 |
| 2020 | 3 | 2 |
| 2021 | 1 | 1 |
| 2022 | 5 | 3 |
| 2023 | 1 | 2 |
| 2024 | 0 | 3 |
| 2025 | 3 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/16743Viral genome or elements thereof as genetic vectorIndexing code81
- C12N 2710/16744Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
- C12N 2710/16745Special targeting system for viral vectorsIndexing code1
- C12N 2710/16742Virus or viral particle as vehicleIndexing code0
Recent patents
- Recombinant herpes zoster vaccine composition and application thereof12 Aug 2025US 12,383,616 B2Immune-Path Biotechnology (Suzhou) Co., Ltd.
- Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex13 May 2025US 12,296,003 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Recombinant virus with diminished latency and methods of using same13 May 2025US 12,296,004 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- EHV insertion site UL437 Mar 2023US 11,596,681 B2
- Non-neuroinvasive viruses and uses thereof20 Sep 2022US 11,447,753 B2Board of Regents of the University of Nebraska
- Herpesviral combination therapy for targeting cancer cells and cancer associated stromal cells11 Jun 2026US 2026/0158087 A1Mayo Foundation for Medical Education and Research
- New feline herpes virus vaccine7 Aug 2025US 2025/0249090 A1Boehringer Ingelheim Vetmedica GmbH
- Pseudorabies virus (prv) expressing porcine circovirus 2 (pcv2) capsid protein on envelope and use thereof5 Dec 2024US 2024/0398937 A1Zhejiang University
- Compositions, methods, models and uses for simian varicella virus (svv) chimeric constructs in human health conditions21 Mar 2024US 2024/0091386 A1Rutgers, The State University of New Jersey
- Bovine herpesvirus type 1 (bohv-1) quadruple gene deleted mutant14 Mar 2024US 2024/0084325 A1The Boards of Supervisors of Louisiana State University and Agricultural and Mechanical College
Most cited
By later US patents
- Porcine circovirus vaccine and diagnostics reagents99US 6,368,601 B1Merial Limited · 2002
- Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence86US 5,223,424 APrutech Research And Development · 1993
- Varicella-zoster virus as a live recombinant vaccine69US 5,310,668 AMerck & Co., Inc. · 1994
- Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-254US 7,211,379 B2Merial Limited · 2007
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000